NCT01304810 - A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Smoking CessationNicotine Dependence

Interventions

BIOLOGICAL

NicVAX vaccine

Prior treatment with NicVAX in Nabi-4514 or Nabi-4515. No intervention in Nabi-4522.

BIOLOGICAL

Placebo

Prior treatment with Placebo in Nabi-4514 or Nabi-4515. No intervention in Nabi-4522.

Trial Locations (12)

NicVAX Investigator, Newport Beach

NicVAX Investigator, San Diego

NicVAX Investigator, Miami

NicVAX Investigator, Boise

NicVAX Investigator, Lexington

NicVAX Investigator, College Park

NicVAX Investigator, Boston

NicVAX Investigator, Rochester

NicVAX Investigator, Raleigh

NicVAX Investigator, Portland

NicVAX Investigator, Norfolk

NicVAX Investigator, Seattle